TMDX
Transmedics Group Stock Analysis
AI Rating
- Quality8/10
- Growth↑ 9/10
- Value↓ 2/10
TMDX Growth
- Revenue Y/Y↑ 37.13%
- EPS Y/Y↑ 423.36%
- FCF Y/Y↑ 265.04%
TMDX Profitability
- Gross margin ↑ 59.90%
- EPS margin↑ 31.40%
- ROIC 5Y↓ 1.53%
TMDX Risk
- Debt / Equity↓ 1.1
- Debt / FCF↓ 0.2
- Interest coverage↑ 8.8
Transmedics Group stock volatility is in-line with the overall market. We give it a Good risk rating.